Nuvectis PharmaNVCT
13F holders, Q4 2024 (December 31)31holders
6new positions
7sold out
1famous investor
$5.41avg. 13F price*
At the end of Q4 2024, 31 institutions reported holding Nuvectis Pharma Inc. (NVCT) in their 13F filings, unchanged from Q3 2024. 6 opened new positions and 7 sold out. The largest holders were Baldwin Wealth Partners LLC ($1.9M), Vanguard Group Inc. ($1.8M) and Marshall Wace, LLP ($674K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Nuvectis Pharma Inc.
- CUSIP
- 67080T108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $298K |
| Exits | 7 | $516K |
All 13F filers, Q3 2024 → Q4 2024: 420,252 shares bought and 148,878 shares sold, net +271,374 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Baldwin Wealth Partners LLC | 0.13% | Add +104.4% | 355,961 | $1.9M |
| Vanguard Group Inc. | 0.00% | Add +8.0% | 325,297 | $1.8M |
| Marshall Wace, LLP | 0.00% | Add +191.0% | 124,571 | $674K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.6% | 79,243 | $429K |
| BlackRock, Inc. | 0.00% | Add +25.8% | 62,342 | $337K |
| Forbes J M & Co. LLP | 0.03% | Add +21.9% | 59,000 | $319K |
| Susquehanna International Group, LLP | 0.00% | Add +72.3% | 45,607 | $247K |
| Gsa Capital Partners LLP | 0.01% | Reduce -30.7% | 34,751 | $188K |
| Qube Research & Technologies Ltd | 0.00% | Add +36.4% | 30,594 | $166K |
| Millennium Management | 0.00% | Reduce -56.6% | 29,698 | $161K |
| Northern Trust Corp. | 0.00% | Add +68.7% | 25,725 | $139K |
| Oppenheimer & Co. Inc. | 0.00% | New | 25,000 | $135K |
| State Street Corp. | 0.00% | Add +43.8% | 22,000 | $119K |
| Squarepoint Ops LLC | 0.00% | New | 19,071 | $103K |
| Two Sigma Investments, LP | 0.00% | Reduce -30.7% | 18,570 | $100K |
| Edmond DE Rothschild Holding S.A. | 0.00% | Reduce -20.9% | 15,170 | $82K |
| Baxter Bros Inc. | 0.01% | Add +20.0% | 15,000 | $81K |
| Nations Financial Group Inc, /Ia/ | 0.01% | Add +35.0% | 13,500 | $73K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 6,294 | $34K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 4,479 | $24K |
| UBS Group AG | 0.00% | Add +24163.6% | 2,669 | $14K |
| Morgan Stanley | 0.00% | Reduce -1.2% | 2,319 | $13K |
| Bank of America Corp. | 0.00% | Add +112.5% | 1,615 | $9K |
| Barclays PLC | 0.00% | No change | 1,144 | $6K |
| Hollencrest Capital Management | 0.00% | Add +42.9% | 400 | $2K |
| R Squared Ltd | 0.00% | — | 310 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -6.8% | 179 | $968 |
| BNP Paribas Financial Markets | 0.00% | New | 115 | $622 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $541 |
| Point72 (DIFC) Ltd | 0.00% | New | 49 | $265 |
| Lanark Financial, Inc. | 0.00% | — | 5 | $27 |
"% of holder's portfolio" is NVCT's weight in each manager's 13F, not the share of Nuvectis Pharma Inc. the manager owns.